• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Special Reports
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Resources
    • About MassDevice
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
    • In-Depth Coverage
    • Latest News
  • Attend DeviceTalks
    • Events
      • DeviceTalks Minnesota – May 4
      • DeviceTalks Boston – May 27–28
      • DeviceTalks West
      • DeviceTalks Tuesdays
    • DeviceTalks Podcast Network
      • DeviceTalks Weekly
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Advertise
  • Subscribe
Home » Oath Surgical emerges from stealth to launch AI-powered surgical centers

Oath Surgical emerges from stealth to launch AI-powered surgical centers

May 15, 2025 By Sean Whooley

Oath Surgical LogoOath Surgical announced its emergence from stealth with the launch of OathOS, an AI-powered surgical operating system.

Portland, Oregon-based Oath Surgical said OathOS marks the first end-to-end operating system for outpatient surgery. Combining proprietary AI technology with its owned-and-operated surgical centers, the company wants to make value-based care in surgery scalable.

Oath Surgical is led by founder and CEO Dr. Oliver Keown, the former head of Intuitive Ventures.

The company says its full-stack solution could solve the underlying inefficiencies of surgical care. Its vertically integrated approach combines proprietary technology and real-world outpatient care in a single, seamless system. The system ranges from integrated proprietary AI scribe and pre-operative referrals to AI-assisted charting and automated recovery follow-up.

Oath Surgical launches with more than $10 million in funding from a number of leading technology, institutional and strategic investors. They include Oxford Science Enterprises, Black Opal Ventures, Rogue VC, Tau Ventures, First Spark Ventures and others. The company acquired two surgical centers in the last year and has a third de novo center in development.

At full capacity, the first sites — both in Portland — could enable thousands of procedures annually. The company estimates cost savings of up to 40% in comparison to hospital-based procedures. Its digital-first facilities support complex, multispecialty care, according to a news release.

“Oath isn’t just layering technology on top of a broken system—we’re rebuilding from the ground up,” said Keown. “OathOS spans digital and physical—from AI to surgical centers—and that vertical integration is what finally makes value-based surgical care real.

“Oath Surgical isn’t just a facility or a software company—it’s a new operating system for surgical care. … We’re rearchitecting the surgical care system around how it should work in 2025 and beyond: digitally integrated, AI-powered, surgeon-led, and built to scale value-based care.”

Filed Under: Artificial Intelligence (AI), Business/Financial News, Digital Health, Funding Roundup, Health Technology, Hospital Care, Machine Learning (ML), Software / IT, Surgical Tagged With: Oath Surgical

More recent news

  • Abbott sets Libre Duo glucose-ketone sensor US launch for December
  • Edwards wins FDA approval for Pascal Precision in tricuspid valve repair
  • Danaher’s Masimo acquisition offsets drops in respiratory diagnostic sales
  • Intuitive stock slides as US procedures slow amid $450M settlement
  • Abbott to spin out Nutrition business, cuts guidance

About Sean Whooley

Sean Whooley is a senior editor who mainly produces work for MassDevice, Medical Design & Outsourcing and Drug Delivery Business News. He received a bachelor's degree in multiplatform journalism from the University of Maryland, College Park. You can connect with him on LinkedIn or email him at [email protected].

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >
MDO ad
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2026 · Arrowfly LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of Arrowfly.

Privacy Policy